2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions

View by Date

Saturday, May 30, 2020

3:51pm-4:03pm: Evaluation of Pre-Transplant T Cell Exhaustion as a Mechanism for Immune Dysfunction and Recipient Risk of Death Following Liver Transplant

K. E. Lunsford¹, N. Aware², K. Cleveland³, D. T. Nguyen⁴, E. A. Graviss⁴, L. J. Minze³, T. N. Eagar⁴, X. C. Li³, R. M. Ghobrial³

Biomarkers, Immune Assessment and Clinical Outcomes IV • Virtual

3:51pm-4:03pm: Evaluation of the Safety and Efficacy of Valganciclovir to Prevent Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients Utilizing Two Dosing Regimens

K. Le, A. Patel, N. M. Jasiak-Panek

CMV and other Herpes Viruses • Virtual

3:51pm-4:03pm: Exosomes Released from Natural Killer Cells Activation of Immune Responses: Role in Chronic Lung Allograft Dysfunction

R. Ravichandran, Y. Itabashi, W. Liu, M. Rahman, S. Bansal, R. Bremner, M. Smith, T. Mohanakumar

Innate Immunity; Chemokines, Cytokines, Complement • Virtual

3:51pm-4:03pm: Extracellular Vesicles Mediate Endothelial to Mesenchymal Transition and Tubular Senescence in Renal Antibody- Mediated Rejection by Inducing Complement Activation

G. Castellano, R. Franzin, A. Stasi, C. Divella, G. Merlotti, M. Quaglia, F. Sallustio, G. Stallone, V. Cantaluppi, L. Gesualdo

Basic: Acute Rejection • Virtual

3:51pm-4:03pm: Factors Predicting Outcome after Living Donor Liver Transplantation in the Era of Intra-Operative Flow Measurements and Inflow Modulation

D. Sonbare, D. Jorgensen, A. Humar

Liver: Living Donors and Partial Grafts II • Virtual

3:51pm-4:03pm: Financial Feasibility of a Culturally Competent and Linguistically Congruent Hispanic Kidney Transplant Program

E. Gordon¹, A. Wang¹, G. McNatt¹, M. Abecassis², J. Caicedo¹

All Organs: Economics & Ethics • Virtual

3:51pm-4:03pm: Generation of Insulin-Producing Cells via Multiplex Epigenetic Engineering of Human Somatic Cells in 2 Weeks

R. A. Naqvi¹, W. Zhang¹, A. Isidan¹, C. Evans-Molina², J. A. Fridell¹, P. Li¹, B. Ekser¹

Islet/Cell Transplantation • Virtual

3:51pm-4:03pm: Health-Related Quality of Life after Anonymous Nondirected Living Liver Donation: A Multi-Center, North American Collaboration

M. H. Raza¹, W. E. Jackson², A. Dell³, L. Ding⁴, J. Shapiro³, E. A. Pomfret⁵, Y. Genyk⁶, L. Sher⁶, J. Emamaullee⁶

Liver: Living Donors and Partial Grafts I • Virtual

3:51pm-4:03pm: Hepatitis C Antibody Seroconversion in Kidney Transplant Patients from HCV Antibody Positive/NAT Negative Donors Does Not Deteriorate Renal Allograft Outcome

R. Rattanavich, M. De Vera, T. Hoang, R. Villicana

Donor Derived Infections • Virtual

3:51pm-4:03pm: HIV+ Living Kidney Donors in the United States: Cases and a Clinical Paradigm

D. Segev¹, C. Wolfe², D. Brown³, D. Fine³, K. Neumann⁴, N. Martinez⁵, D. Ostrander³, F. Al Ammary³, A. Tobian³, A. W. Baker⁶, C. Durand³

Kidney Living Donor: Other I • Virtual